In a recent study posted on bioRxiv* US researchers use a hamster model to study efficacy and immunity of an intranasal messenger ribonucleic acid (mRNA)-lipid nanoparticle...
In a recent study posted on Bio Rxiv*Preprint server, researchers evaluated the efficacy of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine. study: Exosome-Based Multivalent Vaccines:...
A recent study published in the journal Nature NeuroscienceSpanish researchers used a mouse model to study a modified vaccinia virus Ankara (MVA) vector in protecting against...
People with hematological malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, few studies...
People suffering from blood cancers often have weak immune systems and are at increased risk of becoming seriously ill from COVID-19. Moreover, some cancer treatments result...
In a recent study posted on bioRxiv* Researchers report that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant substrains effectively evade B-cell immune responses by...
Recent Comments